Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Microbot Medical Inc.MBOT · Entity 6767 | Director | October 05, 2017 | October 10, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Microbot Medical Inc.
Report date October 05, 2017 · Filed October 10, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,558,390 |
Reported balance
After 2017-10-05 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-10-05 · Sale · Disposed 17,100 · Balance 1,558,390 F1: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 33,700 shares of Issuer common stock on October 5, 2017 and October 9, 2017. Accordingly, Reporting Person beneficially owned 1,558,390 shares of Issuer common stock following the reported transactions. |
| Common StockSEC Table I · non-derivative | Direct | 1,558,390 |
Reported balance
After 2017-10-09 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2017-10-09 · Sale · Disposed 16,600 · Balance 1,558,390 F1: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 33,700 shares of Issuer common stock on October 5, 2017 and October 9, 2017. Accordingly, Reporting Person beneficially owned 1,558,390 shares of Issuer common stock following the reported transactions. |
Filing footnotes · ownership attribution and instrument terms
F1: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 33,700 shares of Issuer common stock on October 5, 2017 and October 9, 2017. Accordingly, Reporting Person beneficially owned 1,558,390 shares of Issuer common stock following the reported transactions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2017 Filed Oct 10, 2017 22:21 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 16,600 | $1.50 | $24,900.00 |
DisclosureSEC source: 0001493152-17-011465 · form4.xml · nonDerivative · entry 2 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,558,390 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 33,700 shares of Issuer common stock on October 5, 2017 and October 9, 2017. Accordingly, Reporting Person beneficially owned 1,558,390 shares of Issuer common stock following the reported transactions. Read SEC document |
| October 05, 2017 Filed Oct 10, 2017 22:21 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 17,100 | $1.50 | $25,679.07 |
DisclosureSEC source: 0001493152-17-011465 · form4.xml · nonDerivative · entry 1 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,558,390 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 33,700 shares of Issuer common stock on October 5, 2017 and October 9, 2017. Accordingly, Reporting Person beneficially owned 1,558,390 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 200 | $1.32 | $264.00 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 15 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 7,490 | $1.31 | $9,811.90 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 14 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 1,471 | $1.31 | $1,919.66 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 13 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 6,500 | $1.30 | $8,450.00 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 12 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 9,001 | $1.30 | $11,656.30 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 11 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 6,463 | $1.29 | $8,337.27 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 10 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 11,083 | $1.29 | $14,241.66 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 9 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 14,400 | $1.28 | $18,432.00 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 8 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 1,200 | $1.28 | $1,530.00 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 7 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 27,384 | $1.27 | $34,777.68 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 6 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 400 | $1.27 | $507.00 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 5 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 20,276 | $1.27 | $25,649.14 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 4 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 40,500 | $1.26 | $51,030.00 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 3 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 28,657 | $1.26 | $35,964.54 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 2 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
| September 15, 2017 Filed Sep 25, 2017 21:48 UTC | Microbot Medical Inc. MBOT · Entity 6767 | SaleCommon Stock | 74,975 | $1.25 | $93,718.75 |
DisclosureSEC source: 0001493152-17-010887 · form4.xml · nonDerivative · entry 1 Shoham Moshe · CIK 0001690161 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,592,090 F1 · balance_after: Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 250,000 shares of Issuer common stock on September 15, 2017. Accordingly, Reporting Person beneficially owned 1,592,090 shares of Issuer common stock following the reported transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.